NCT07782333 · Triveni Bio
A Study Evaluating TRIV-573 in Atopic Dermatitis
What this study is about
The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomly assigned to (TRIV-573 or placebo).
View original scientific description
The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo). The study duration for individual participants is up to 40 weeks, including a Screening period of up to 30 days.
Interventions
DRUG
TRIV-573
TRIV-573 (Subcutaneous injection)
DRUG
Placebo
Placebo (Matching Placebo subcutaneous injection)
Primary outcome measures
Percentage of participants with improvement of AD
Time frame: Baseline through Week 16
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Has Atopic Dermatitis.
- Has moderate to severe, active and symptomatic atopic dermatitis.
Exclusion criteria
- Severe or uncontrolled medical conditions.
- Use of prohibited medications within stated washout periods.
Where
- Fountain Valley, California
- Los Angeles, California
- Boca Raton, Florida
- Miami, Florida
- Indianapolis, Indiana
- Bay City, Michigan
- Boardman, Ohio
- Camp Hill, Pennsylvania
- Myrtle Beach, South Carolina
- San Antonio, Texas
- Spokane, Washington
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Oct 28, 2026 · Source of record for eligibility and locations